Xylem Inc. (XYL) Financial Statements
Xylem Inc. (XYL) reported trailing twelve-month revenue of $9.1B (up 4.5% year on year) and net income of $1.0B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $960.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
XYLXylem Inc.Follow XYL — free
—
Price chart with a free account
- Market cap
- 25.4B
- P/E TTM
- 25.9
- Dividend yield
- 1.5%
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.80 | 3.79 | 3.84 | 3.92 | 3.65 | 3.77 | 4.71 | 5.21 | 5.25 | 4.88 | 5.20 | 5.52 | 7.36 | 8.56 | 9.04 | 9.13 | |
| Gross profit | 1.46 | 1.50 | 1.50 | 1.51 | 1.40 | 1.46 | 1.85 | 2.03 | 2.05 | 1.83 | 1.98 | 2.08 | 2.72 | 3.21 | 3.48 | 3.58 | |
| Research & development | 0.10 | 0.11 | 0.10 | 0.10 | 0.10 | 0.11 | 0.18 | 0.19 | 0.19 | 0.19 | 0.20 | 0.21 | 0.23 | 0.23 | 0.23 | 0.23 | |
| Operating income | 0.40 | 0.44 | 0.36 | 0.46 | 0.45 | 0.41 | 0.55 | 0.65 | 0.49 | 0.37 | 0.59 | 0.62 | 0.65 | 1.01 | 1.22 | 1.32 | |
| Pre-tax income | 0.38 | 0.39 | 0.30 | 0.42 | 0.40 | 0.34 | 0.47 | 0.59 | 0.42 | 0.29 | 0.51 | 0.44 | 0.64 | 1.09 | 1.18 | 1.27 | |
| Income tax | 0.10 | 0.09 | 0.07 | 0.08 | 0.06 | 0.08 | 0.14 | 0.04 | 0.02 | 0.03 | 0.08 | 0.09 | 0.03 | 0.20 | 0.23 | 0.26 | |
| Net income | 0.28 | 0.30 | 0.23 | 0.34 | 0.34 | 0.26 | 0.33 | 0.55 | 0.40 | 0.25 | 0.43 | 0.36 | 0.61 | 0.89 | 0.96 | 1.02 | |
| Diluted EPS ($) | 1.50 | 1.59 | 1.22 | 1.83 | 1.87 | 1.45 | 1.83 | 3.03 | 2.21 | 1.40 | 2.35 | 1.96 | 2.79 | 3.65 | 3.92 | 4.20 | |
| Diluted shares (bn) | 0.185 | 0.186 | 0.186 | 0.184 | 0.182 | 0.180 | 0.181 | 0.181 | 0.181 | 0.181 | 0.182 | 0.181 | 0.218 | 0.244 | 0.244 | — |
USD billions · SEC XBRL
Xylem Inc. — questions
- What is Xylem Inc.'s revenue?
- $9.1B over the twelve months to 2026-06-30, up 4.5% year on year, from its 10-Q and 10-K filings.
- What is Xylem Inc.'s net income?
- $1.0B over the twelve months to 2026-06-30.
- What is Xylem Inc.'s free cash flow?
- $960.0M over the twelve months to 2026-06-30.
- What are Xylem Inc.'s diluted earnings per share?
- $4.20 over the twelve months to 2026-06-30.
Every figure on this page comes from Xylem Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.